Neurocrine Biosciences Inc. monthly returns
Neurocrine Biosciences Inc. has averaged 2.14% a month with dividends reinvested, and risen in 51% of months, through November 17, 2026. The table lists the most recent months; the chart, the last 5 years.
Month by month#
Data provided bySource: Twelve Data| Month | Path | Total return |
|---|---|---|
| Nov 2026 | +13.6% | |
| Oct 2026 | +3.0% | |
| Sep 2026 | -7.9% | |
| Aug 2026 | -7.7% | |
| Jul 2026 | -1.0% | |
| Jun 2026 | +6.5% | |
| May 2026 | +20.2% | |
| Apr 2026 | -0.1% | |
| Mar 2026 | -0.4% | |
| Feb 2026 | -2.8% | |
| Jan 2026 | -4.1% | |
| Dec 2025 | -6.8% | |
| Nov 2025 | +6.2% | |
| Oct 2025 | +2.0% | |
| Sep 2025 | +0.6% | |
| Aug 2025 | +8.9% | |
| Jul 2025 | +2.0% | |
| Jun 2025 | +2.2% | |
| May 2025 | +14.2% | |
| Apr 2025 | -2.6% | |
| Mar 2025 | -6.8% | |
| Feb 2025 | -21.8% | |
| Jan 2025 | +11.2% | |
| Dec 2024 | +7.7% | |
| Nov 2024 | +5.4% | |
| Oct 2024 | +4.4% | |
| Sep 2024 | -9.3% | |
| Aug 2024 | -10.2% | |
| Jul 2024 | +2.8% | |
| Jun 2024 | +1.7% | |
| May 2024 | -1.5% | |
| Apr 2024 | -0.3% | |
| Mar 2024 | +5.8% | |
| Feb 2024 | -6.7% | |
| Jan 2024 | +6.1% | |
| Dec 2023 | +13.0% | |
| Nov 2023 | +5.1% | |
| Oct 2023 | -1.4% | |
| Sep 2023 | +3.3% | |
| Aug 2023 | +6.9% | |
| Jul 2023 | +8.0% | |
| Jun 2023 | +5.3% | |
| May 2023 | -11.4% | |
| Apr 2023 | -0.2% | |
| Mar 2023 | -1.8% | |
| Feb 2023 | -7.1% | |
| Jan 2023 | -7.1% | |
| Dec 2022 | -6.0% | |
| Nov 2022 | +10.4% | |
| Oct 2022 | +8.4% | |
| Sep 2022 | +1.5% | |
| Aug 2022 | +11.2% | |
| Jul 2022 | -3.4% | |
| Jun 2022 | +4.3% | |
| May 2022 | +3.8% | |
| Apr 2022 | -4.0% | |
| Mar 2022 | +4.3% | |
| Feb 2022 | +13.7% | |
| Jan 2022 | -7.2% | |
| Dec 2021 | +2.3% | |
| Nov 2021 | -21.0% | |
| Oct 2021 | +9.9% | |
| Sep 2021 | +0.7% | |
| Aug 2021 | +2.1% | |
| Jul 2021 | -4.2% | |
| Jun 2021 | +1.1% | |
| May 2021 | +1.8% | |
| Apr 2021 | -2.8% | |
| Mar 2021 | -11.2% | |
| Feb 2021 | -0.2% | |
| Jan 2021 | +14.5% | |
| Dec 2020 | +1.0% | |
| Nov 2020 | -3.8% | |
| Oct 2020 | +2.6% | |
| Sep 2020 | -17.4% | |
| Aug 2020 | -3.3% | |
| Jul 2020 | -1.3% | |
| Jun 2020 | -2.2% | |
| May 2020 | +27.1% | |
| Apr 2020 | +13.4% | |
| Mar 2020 | -8.6% | |
| Feb 2020 | -5.4% | |
| Jan 2020 | -6.9% | |
| Dec 2019 | -7.8% | |
| Nov 2019 | +17.2% | |
| Oct 2019 | +10.4% | |
| Sep 2019 | -9.4% | |
| Aug 2019 | +3.1% | |
| Jul 2019 | +14.2% | |
| Jun 2019 | -0.4% | |
| May 2019 | +17.4% | |
| Apr 2019 | -18.0% | |
| Mar 2019 | +14.0% | |
| Feb 2019 | -12.4% | |
| Jan 2019 | +23.5% | |
| Dec 2018 | -19.1% | |
| Nov 2018 | -17.6% | |
| Oct 2018 | -12.9% | |
| Sep 2018 | +0.0% | |
| Aug 2018 | +22.4% | |
| Jul 2018 | +2.3% | |
| Jun 2018 | +2.1% | |
| May 2018 | +18.7% | |
| Apr 2018 | -2.2% | |
| Mar 2018 | -1.8% | |
| Feb 2018 | -1.2% | |
| Jan 2018 | +10.2% | |
| Dec 2017 | +7.9% | |
| Nov 2017 | +15.7% | |
| Oct 2017 | +1.4% | |
| Sep 2017 | +8.3% | |
| Aug 2017 | +17.8% | |
| Jul 2017 | +4.4% | |
| Jun 2017 | +5.8% | |
| May 2017 | -18.6% | |
| Apr 2017 | +23.3% | |
| Mar 2017 | -1.9% | |
| Feb 2017 | +2.9% | |
| Jan 2017 | +10.9% | |
| Dec 2016 | -16.7% |
Monthly total return (since Dec 2021)#
Neurocrine Biosciences Inc. returns by calendar month#
Every month of every year since 1996, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
November 2026 so far: +13.57% — 5th of 31 Novembers since 1996 at the last close; the average November returned +3.9%.
| Month | −95%0+95% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +6.4% | +1.0% | 50% | +83.0% 2014 | -24.8% 2016 | |
| Feb | -1.5% | -2.9% | 30% | +55.8% 2000 | -33.1% 2001 | |
| Mar | -0.9% | -1.3% | 40% | +14.9% 2013 | -37.2% 2000 | |
| Apr | -1.2% | -2.7% | 33% | +25.9% 2010 | -19.0% 2002 | |
| May | +5.4% | +7.2% | 60% | +43.6% 2001 | -65.6% 2006 | |
| Jun | +2.1% | +1.7% | 55% | +67.4% 2000 | -46.2% 2006 | |
| Jul | -0.2% | -0.9% | 48% | +28.1% 2002 | -20.5% 1999 | |
| Aug | +1.9% | +1.5% | 52% | +29.5% 2000 | -42.9% 1998 | |
| Sep | +2.4% | +0.6% | 55% | +46.9% 1998 | -22.3% 2013 | |
| Oct | +3.0% | +2.6% | 58% | +34.3% 2010 | -27.2% 2009 | |
| Nov | +3.9% | +4.3% | 60% | +91.0% 1999 | -25.0% 2000 | |
| Dec | +4.0% | +3.1% | 63% | +86.8% 1999 | -65.1% 2007 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from NBIX's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Neurocrine Biosciences Inc.'s average monthly return?
- Neurocrine Biosciences Inc. has averaged about 2.14% per month (dividends reinvested), positive in roughly 51% of months. The best month was Nov 1999 (+91.0%) and the worst was May 2006 (-65.6%).
